Prevalence and common cardiovascular risk factors in aortic valve calcification in the middle-aged general populationShow others and affiliations
2025 (English)In: European Journal of Preventive Cardiology, ISSN 2047-4873, E-ISSN 2047-4881, Vol. 32, no 17, p. 1694-1702Article in journal (Refereed) Published
Abstract [en]
Aims Aortic valve calcification (AVC) is an underlying pathophysiological mechanism for aortic stenosis that is common in the elderly, but less is known in younger individuals. The aim was to study the prevalence and associated characteristics of AVC in a middle-aged general population. Methods and results Data were obtained from the Swedish CArdioPulmonary bioImage Study (SCAPIS) comprising 30 154 individuals 50-64 years from the general population recruited in Sweden between 2013 and 2018. Aortic valve calcification was assessed visually on computed tomography (CT) and categorized as evident or not. Population attributable risk proportion (PARP) was calculated for six modifiable risk factors (smoking, hypertension, hyperlipidaemia, diabetes, body mass index (BMI) >= median, and kidney dysfunction [estimated glomerular filtration rate < 60 mL/min/1.73 m(2)]). In total, 29 221 individuals with CT images available were included (mean age 57.5 years, 51% female) and AVC was present in 2053 (7%). The AVC prevalence increased with age (50-54 years: 3%; 55-59 years: 7%; 60-64 years: 11%). In analyses adjusted for age, sex, smoking, and study site, male sex (OR 2.02, 95% CI 1.84-2.22), hyperlipidaemia (1.88 [1.68-2.11]), hypertension (1.73 [1.57-1.91]), diabetes (1.66 [1.39-1.97]), kidney dysfunction (1.54 [1.10-2.11]), smoking (1.36 [1.24-1.50]), age (increment by one year) (1.12 [1.11-1.13]), and BMI (increment by one unit) (1.04 [1.03-1.05]) were associated with AVC. The PARP of AVC associated with the six modifiable risk factors was 34.5% (95% CI 29.6-39.4). Conclusion In this large, contemporary middle-aged general population, AVC was prevalent in as many as 7% and six cardiovascular risk factors contributed to one-third of the prevalence of AVC.
Place, publisher, year, edition, pages
OXFORD UNIV PRESS , 2025. Vol. 32, no 17, p. 1694-1702
Keywords [en]
Aortic valve calcification; Aortic stenosis; Prevention; Hypertension; Hyperlipidaemia; Cardiovascular prevention; Epidemiology
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:liu:diva-213173DOI: 10.1093/eurjpc/zwaf157ISI: 001461757500001PubMedID: 40114420OAI: oai:DiVA.org:liu-213173DiVA, id: diva2:1953972
Note
Funding Agencies|Swedish CArdioPulmonary bioImage Study (SCAPIS) is the Swedish Heart-Lung Foundation; Knut and Alice Wallenberg Foundation; Swedish Research Council; VINNOVA (Sweden's Innovation agency) the University of Gothenburg and Sahlgrenska University Hospital; Karolinska Institutet and Stockholm County Council; Linkoeping University; University Hospital; Lund University; Skane University Hospital; Umea University; Uppsala University; University Hospital; Swedish Heart-Lung Foundation [20210578]; Stockholm County Council [FoUI-988371]; Swedish Heart-Lung Foundation [20220524]; Swedish Research Council [2022-01472]; Swedish Society for Medical Research (SSMF) [SG-23-0142-B]; Swedish Society of Medicine (SLS) [987010]; Karolinska Institutet [2-116/2023]
2025-04-232025-04-232025-12-10